Endothelial dysfunction in children with type 1 diabetes mellitus (Q34636106)

3 August 2017

1 reference

title

Endothelial dysfunction in children with type 1 diabetes mellitus. (English)

1 reference

3 August 2017

0 references

0 references

Mariapina Pomilio

1

1 reference

3 August 2017

Angelika Mohn

series ordinal

2

1 reference

3 August 2017

Alberto Verrotti

series ordinal

3

1 reference

3 August 2017

Francesco Chiarelli

series ordinal

4

1 reference

3 August 2017

language of work or name

1 reference

1 April 2002

1 reference

Journal of Pediatric Endocrinology and Metabolism

3 August 2017

1 reference

3 August 2017

15

1 reference

3 August 2017

4

1 reference

3 August 2017

343-361

1 reference

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

3 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Glucose: a continuous risk factor for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

HIV cardiomyopathy: a dark cloud with a silver lining?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Biosynthesis of von Willebrand protein by human megakaryocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Endothelial dysfunction and pathogenesis of diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Impairment of nitric oxide-mediated relaxations in anaesthetized autoperfused streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

The role of anti-oxidative treatment in diabetes mellitus. This meeting was held in Frankfurt am Main, Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

The oxidant stress of hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2002.15.4.343

10.1515/JPEM.2002.15.4.343

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference